Abstract: The present disclosure relates to an isolated anti-FcRN antibody, which is an antibody binding to FcRN (stands for neonatal Fc receptor, also called FcRP, FcRB or Brambell receptor) that is a receptor with a high affinity for IgG or a fragment thereof, a method of preparing thereof, a composition for treating autoimmune disease, which comprises the antibody, and a method of treating and diagnosing autoimmunre diseases using the antibody. The FcRn-specific antibody according to the present disclosure binds to FcRn non-competitively with IgG to reduce serum pathogenic auto-antibody levels, and thus can be used for the treatment of autoimmune diseases.

Abstract: A functional feeding cushion including: a cushion body formed of an inner cover and a cushion material charged inside the inner cover; a hip receiving portion sunken from a front surface of the cushion body; an upper body receiving portion sunken from the front surface of the cushion body; an outer cover covering the front surface of the cushion body and having a cover body; a fixation band vertically disposed at a center of a front surface of the cover body; and a strap horizontally passing under the fixation band and configured to cover and wrap a body portion of the infant. The upper body receiving portion has a predetermined depth decreasing gradually towards an upper end of the upper body receiving portion, and a predetermined width decreasing gradually towards the upper end of the upper body receiving portion while forming a left-right symmetrical trapezoidal shape.

Abstract: The present invention relates to a composition containing an inducer of SIRT1 (silent mating type information regulation 2 homolog) expression for preventing or treating sepsis or septic shock. The inducer of SIRT1 expression can remarkably reduce the mortality caused by sepsis or septic shock by reducing pro-inflammatory cytokines and increasing anti-inflammatory cytokines. Therefore, the inducer of SIRT1 expression is useful for preventing or treating sepsis or septic shock.

Abstract: Provided is a functional feeding cushion, and more particularly, to a functional feeding cushion in which an outer cover to which a fixation band is coupled is used and the outer cover is used while covering a cushion body and as necessary, at least one of a striped cover, a side cushion, a lower cushion, etc., may be coupled and used. Further provided is a functional outer cover for a feeding cushion, which includes: a cover body covered as an outer cover of a feeding cushion for an infant; and a fixation band vertically disposed at the center of a front surface of the cover body on which an infant's body is placed and having upper and lower ends coupled to the cover body.

Abstract: A pharmaceutical composition for preventing or treating cartilage diseases, and pharmaceutical preparation that includes the pharmaceutical composition as an active ingredient are provided. The pharmaceutical composition includes, as an active ingredient, at least one of an integrin beta-like 1 (ITGBL1) protein, ITGBL1 DNA or RNA encoding the ITGBL1 protein.

Abstract: A pharmaceutical composition for preventing or treating cartilage diseases, and pharmaceutical preparation that includes the pharmaceutical composition as an active ingredient are provided.

Abstract: There are provided a food container having a silicon incorporated diamond like carbon (Si-DLC) layer and a method thereof. The food container includes a container made of a plastic material; an intermediate thin layer formed on a surface of the container; and a Si-DLC layer formed on the intermediate thin layer. Accordingly, it is possible to provide porous plastic container having a Si-DLC layer and a manufacturing method thereof, which can implement high oxygen barrier properties and excellent mechanical characteristics by stably depositing a Si-DLC layer on a food container having lower surface energy without breaking the Si-DLC layer.

Abstract: The present invention relates to a composition containing an inducer of SIRT1 (silent mating type information regulation 2 homolog) expression for preventing or treating sepsis or septic shock. The inducer of SIRT1 expression can remarkably reduce the mortality caused by sepsis or septic shock by reducing pro-inflammatory cytokines and increasing anti-inflammatory cytokines. Therefore, the inducer of SIRT1 expression is useful for preventing or treating sepsis or septic shock.

Abstract: The present invention relates to a composition containing an inducer of SIRT1 (silent mating type information regulation 2 homolog) expression for preventing or treating sepsis or septic shock. The inducer of SIRT1 expression can remarkably reduce the mortality caused by sepsis or septic shock by reducing pro-inflammatory cytokines and increasing anti-inflammatory cytokines. Therefore, the inducer of SIRT1 expression is useful for preventing or treating sepsis or septic shock.

Abstract: The present invention relates to a food container made of a plastic material and having a nano-structured hydrophobic surface, including: a plurality of nano-structures formed on a surface of the food container; and a first hydrophobic thin film coated on an upper side of the surface, on which the nano-structures are formed, and a manufacturing method thereof. According to the present invention, it is possible to provide the food container having the nano-structured hydrophobic surface capable of having excellent gas blocking performance, as well as hydrophobicity, and the manufacturing method thereof.

Abstract: There are provided a food container having a silicon incorporated diamond like carbon (Si-DLC) layer and a method thereof. The food container includes a container made of a plastic material; an intermediate thin layer formed on a surface of the container; and a Si-DLC layer formed on the intermediate thin layer. Accordingly, it is possible to provide porous plastic container having a Si-DLC layer and a manufacturing method thereof, which can implement high oxygen barrier properties and excellent mechanical characteristics by stably depositing a Si-DLC layer on a food container having lower surface energy without breaking the Si-DLC layer.

Abstract: There are provided a food container having improved oxygen barrier properties and a manufacturing method thereof. The food container includes a container made of a plastic material, a buffer thin layer formed on a surface of the container and having a thickness of 5 to 30 nm, and an oxygen barrier thin layer formed on the buffer thin layer. Accordingly, it is possible to provide a food container and a manufacturing method thereof, which can remarkably improve oxygen barrier properties by depositing, using a plasma method, an oxygen barrier thin layer on a porous plastic container having low surface energy without breaking the oxygen barrier thin layer.

Abstract: The present invention relates to a food container made of a plastic material and having a nano-structured hydrophobic surface, including: a plurality of nano-structures formed on a surface of the food container; and a first hydrophobic thin film coated on an upper side of the surface, on which the nano-structures are formed, and a manufacturing method thereof. According to the present invention, it is possible to provide the food container having the nano-structured hydrophobic surface capable of having excellent gas blocking performance, as well as hydrophobicity, and the manufacturing method thereof.

Abstract: The present invention relates to a composition containing an inducer of SIRT1 (silent mating type information regulation 2 homolog) expression for preventing or treating sepsis or septic shock. The inducer of SIRT1 expression can remarkably reduce the mortality caused by sepsis or septic shock by reducing pro-inflammatory cytokines and increasing anti-inflammatory cytokines. Therefore, the inducer of SIRT1 expression is useful for preventing or treating sepsis or septic shock.

Abstract: The present invention relates to a trehalose-producing microorganism and a process for producing trehalose. It also to a novel trehalose synthase protein, a trehalose synthase gene, recombinant plasmids carrying said trehalose synthase gene, and transformed microorganism with said recombinant plasmids.